AstraZeneca's Imfinzi combined with Pfizer's Padcev cuts the risk of death from bladder cancer by 42%
Predicted impact: Low
Predicted impact: Low
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.